Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Modulight Oyj (MODU.HE)
EUR1.13
+0.05 (+4.65%)
FI HEL Healthcare Medical - Devices
Address
Hermiankatu 22 33720
Tampere, FI
Tampere, FI
CEO
Seppo Orsila
Website
modulight.com
IPO
2021-09-29
ISIN FI4000511506
Description
Modulight Oyj designs, manufactures, and markets lasers products for medical and other diagnostic applications. The company offers laser products for clinical applications, biomedical illumination, and ophthalmology; plug and play laser systems; laser modules and components; and diode laser chips, bars, and wafers. The company was incorporated in 2000 and is based in Tampere, Finland.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR1.13
+0.05 (+4.65%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
22.7K
Beta
1.76
Float Shares
14.98M
Free Float %
35.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.05% | +9.21% | +2.89% | +12.16% | +7.33% | +7.33% | +6.41% | -45.03% | -88.62% | -88.62% | -88.62% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.13
Ratings Trend (MoM)
50% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
6.47
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+72.6% ★ Q1'26: -6.9% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+26.7% Q1'26: +47.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-89.4% Q1'26: -11.6% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%-65.8% Q1'26: -71.2% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%-12.3% Q1'26: -11.5% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%-1.5% ★ Q1'26: +12.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-16.61× Q1'26: 1.89× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
9.07M
est: 12.90M (-29.7%)
|
4.60M
est: 4.60M (0.0%)
|
4.03M
est: 6.50M (-38.1%)
|
4.10M
est: 4.13M (-0.9%)
|
7.07M
est: 7.49M (-5.7%)
|
8.25M
8.00M – 8.50M
+10.1% YoY
|
12.12M
11.02M – 13.22M
+46.9% YoY
|
17.02M
17.01M – 17.03M
+40.4% YoY
|
17.74M
16.56M – 18.91M
+4.2% YoY
|
| EBITDA |
-3.69M
est: -7.31M (+49.6%)
|
-6.57M
est: -2.61M (-151.8%)
|
-10.72M
est: -4.46M (-140.3%)
|
-4.22M
est: -2.84M (-48.8%)
|
-168.0K
est: -5.14M (+96.7%)
|
-5.66M
-5.83M – -5.49M
-10.1% YoY
|
-8.31M
-9.07M – -7.56M
-46.9% YoY
|
-11.67M
-11.68M – -11.67M
-40.4% YoY
|
-12.17M
-12.98M – -11.36M
-4.2% YoY
|
| EBIT |
-4.90M
est: -7.93M (+38.2%)
|
-8.42M
est: -2.83M (-197.8%)
|
-12.13M
est: -5.46M (-122.3%)
|
-6.24M
est: -3.47M (-79.7%)
|
-4.65M
est: -6.29M (+26.1%)
|
-6.92M
-7.13M – -6.72M
-10.1% YoY
|
-10.17M
-11.10M – -9.25M
-46.9% YoY
|
-14.29M
-14.29M – -14.28M
-40.4% YoY
|
-14.89M
-15.88M – -13.90M
-4.2% YoY
|
| Net Income |
-5.06M
est: 1.70M (-397.9%)
|
-9.31M
est: -8.01M (-16.2%)
|
-11.86M
est: -11.85M (-0.1%)
|
-6.45M
est: -7.81M (+17.5%)
|
-4.61M
est: -4.85M (+5.1%)
|
-3.10M
-3.48M – -2.92M
+36.1% YoY
|
-2.05M
-2.16M – -1.82M
+33.9% YoY
|
250.0K
245.8K – 292.2K
+112.2% YoY
|
776.7K
709.7K – 843.6K
+210.7% YoY
|
| SGA |
6.43M
est: 15.66M (-58.9%)
|
7.60M
est: 5.58M (+36.0%)
|
-243.0K
est: 8.15M (-103.0%)
|
14.30M
est: 5.18M (+176.1%)
|
3.35M
est: 9.39M (-64.4%)
|
10.34M
10.02M – 10.65M
+10.1% YoY
|
15.18M
13.80M – 16.57M
+46.9% YoY
|
21.32M
21.31M – 21.33M
+40.4% YoY
|
22.23M
20.75M – 23.70M
+4.2% YoY
|
| EPS |
-0.12
est: 0.04 (-400.0%)
|
-0.22
est: -0.20 (-12.8%)
|
-0.28
est: -0.28 (+0.0%)
|
-0.15
est: -0.19 (+19.6%)
|
-0.11
est: -0.12 (+5.1%)
|
-0.08
-0.08 – -0.07
+34.0% YoY
|
-0.05
-0.05 – -0.04
+37.8% YoY
|
0.01
0.01 – 0.01
+113.5% YoY
|
0.02
0.02 – 0.02
+188.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
1.46M
OE per share TTM
0.04
Owner's Yield
2.44%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
233.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
-73.8K
Shares Outstanding
42.49M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Seppo Orsila | Chief Executive Officer & Non-Independent Director | 251.0K | male |
| Petteri Uusimaa | Chief Technology Officer | 203.2K | — |
| Kati Reiman | People & Culture Director | — | female |
| Anca Guina | Chief Financial Officer | — | female |
| Jari Sillanpää | Vice President of Sales | — | male |
| Ulla Haapanen | Marketing Director | — | female |
| Ville Vilokkinen | Vice President of Operations | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MODU.HE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
